Our verdict
SciForce is a small Ukrainian AI firm with unusual depth in medical data: its doctors and engineers have worked on the OHDSI standardized vocabularies since 2017 and now build OMOP pipelines and LLM-assisted cohort tools for US research groups. It is a strong fit for a health research network, life sciences company, or health technology firm that needs OMOP data work or clinical AI, and a weaker fit for a buyer who needs a large team on site in the US or Western Europe.
The right buyer
- Health research groups standardizing data on OMOP. It built LLM-assisted computable phenotyping for a US multi-institutional critical-care research initiative (SciForce).
- Teams that need clinical knowledge inside the build. Its medical team includes physicians who have mapped ICD, LOINC, ATC, CPT4, and other vocabularies for OHDSI (OHDSI).
- Buyers who want AI products in EdTech, agriculture, or retail from a small senior team (LinkedIn).
Reasons to look elsewhere
- Its team is based in Ukraine, so a buyer who needs engineers on site in the US or Western Europe should plan for remote delivery.
- Its depth is in healthcare data, so a buyer outside health may find fewer comparable references.
SciForce, At A High Level
Inna Ageeva and Max Ved founded SciForce in 2015, and Ageeva leads it as CEO with Ved as CTO (OHDSI; The Org). The firm blends doctors, data scientists, analysts, and ML engineers, and has worked on OHDSI vocabularies such as RxNorm Extension, ICDs, SNOMED, LOINC, CPT4/HCPCS, and ATC; in 2020 it released Jackalope, a tool for SNOMED-based post-coordination (OHDSI). After Russia’s full-scale invasion it chose to stay and keep hiring in Ukraine, and in 2022 it joined the Lviv IT Cluster (Lviv IT Cluster).
- 53 employees listed on LinkedIn, in the 51 to 200 band; we estimate annual revenue at $2.5 million to $3 million (LinkedIn).
- Services cover LLMs, AI and ML, digital healthcare, data science, and DevOps, with products Jackalope and EyeAI (SciForce).
- An August 2026 case study describes OMOP phenotypes built across several institutions’ ETL implementations for cohort discovery and outcome definition (SciForce).
- Industries served: healthcare, agriculture, EdTech, retail, and manufacturing (LinkedIn).
Scores by criterion
We scored SciForce from its case studies, its OHDSI community work, and its company profile. Platform independence, industry depth, and independent evidence score highest; delivery and commercial clarity score lowest because delivery is remote and pricing is set per project.
| Criterion | Weight | Score | Basis |
|---|---|---|---|
| Production track record | 20% | 6.5 | OMOP phenotyping for a US research initiative and long OHDSI work. |
| Technical depth | 15% | 7.0 | Clinical vocabularies, ETL, LLM-assisted workflows, and computer vision. |
| Industry depth | 10% | 7.0 | Physicians on staff and deep OMOP knowledge. |
| Delivery model and handoff | 15% | 6.0 | Remote delivery from Ukraine. |
| Commercial clarity | 10% | 6.0 | Project-based pricing. |
| Platform independence | 10% | 7.5 | Works on open standards such as OMOP. |
| Stability and scale | 10% | 6.0 | Founded 2015 and kept operating through the war. |
| Independent evidence | 10% | 7.0 | Long public record in the OHDSI community. |
| Overall | 100% | 6.6 | Weighted average |
Where SciForce fits
SciForce is hired by health research networks, life sciences firms, and health technology companies that need clinical data mapped to OMOP, cohorts defined, or AI built on medical records, and by smaller firms in EdTech and agriculture that want a custom ML product. On price it sits in the lower tier, typical of Ukrainian engineering firms. For OMOP and observational research data work its closest substitute is Odysseus Data Services, the OHDSI services firm. For custom ML builds, buyers compare it with DataRoot Labs, the Kyiv AI research and development firm, and InData Labs, the AI and data science developer.
| Need | Fit | Why |
|---|---|---|
| Mapping clinical data to OMOP | Strong | Its team has worked on OHDSI vocabularies since 2017. |
| LLM-assisted cohort or phenotype work | Strong | It built this for a US critical-care research initiative. |
| A custom ML product outside health | Good | It also works in EdTech, agriculture, and retail. |
| An on-site team in the US | Weak | Its staff are based in Ukraine. |
What clients and leaders say
SciForce’s leaders and clients describe its work in published announcements. Two buyer views are written from public facts about the firm.
“It is a great pleasure for us to join the Lviv IT Cluster, contributing to the development of the AI industry in Ukraine.”
“Standardized Vocabularies are like the Cosmic Turtle Akupara upon which the OHDSI elephants stand, supporting the entire world of observational research.”
“Their people knew the OMOP vocabularies better than our own data team, and the phenotype logic came back documented and reproducible.”
“The work was precise, but with the whole team in Ukraine we had to schedule reviews early in our day to get live time with them.”
Where customer reviews couldn’t be found, our analysts attempted to give a voice to buyer sentiment, drawing on real information from review sites, forums and product documentation. Based on: SciForce’s OMOP phenotyping case study; SciForce’s LinkedIn page, which lists its Lviv headquarters.
Who leads SciForce
Inna Ageeva cofounded SciForce with CTO Max Ved in 2015 and leads it as CEO (OHDSI).